Meg Clancy is a seasoned professional in oncology analytics with extensive experience in market research and competitive intelligence. Currently serving as a Senior Manager at Eisai US since January 2016, Meg specializes in secondary data analysis and primary market research for Halaven in metastatic breast cancer and soft tissue sarcoma. Prior roles include Research Director at BioVid Corporation, where responsibilities included client engagement and project management, and Director at Ipsos, focusing on primary research within oncology. With a long tenure at Synovate, Meg held multiple positions including Vice President, leading research teams across various therapeutic areas. Educational qualifications include a Bachelor's degree in Geology with minors in Economics and German from Allegheny College, and a Bachelor of Business Administration in Marketing from Ramapo College of New Jersey.
This person is not in any teams
This person is not in any offices